We build the exact model your study needs.

Designed and delivered by ingenious targeting laboratory. Quote in 24 hours.

Get a Quote
Skip to main content
Uncertain NIH funding? Start now, pay later.
Back to Glossary
Immunology & Humanization

HLA Humanized Models

Genetically engineered mice in which murine major histocompatibility complex (MHC) genes are replaced with human leukocyte antigen (HLA) alleles. These models recapitulate key aspects of human antigen presentation and adaptive immunity.

Overview

HLA humanized models are genetically engineered mice in which murine major histocompatibility complex (MHC) genes are replaced with human leukocyte antigen (HLA) alleles. These models recapitulate key aspects of human antigen presentation and adaptive immunity.

Frequently Asked Questions

What applications benefit from HLA humanization?

Vaccine development, cancer immunotherapy research, autoimmunity studies, and evaluation of HLA-restricted T-cell receptor therapies.

Related Services

Related Terms

Humanized Immune Checkpoint (PD-1 / PD-L1 / CTLA-4)

Genetically engineered mice with key inhibitory immune receptors, such as PD-1, PD-L1, and CTLA-4, replaced with their human equivalents. Essential for evaluating antibody and biologic therapies targeting immune checkpoint pathways.

Cytokine / Receptor Humanization

The genetic replacement of mouse cytokines, receptors, or ligand, receptor pairs with their human equivalents. These models recreate critical components of the human immune network for accurate evaluation of human biologics.

Graft-versus-Host / Engraftment Considerations

Immunological compatibility factors that influence successful transplantation and maintenance of human cells or tissues in humanized mouse models. These parameters determine whether engrafted human immune systems function properly.

More in Immunology & Humanization

Humanized Immune Checkpoint (PD-1 / PD-L1 / CTLA-4)Cytokine / Receptor HumanizationSingle vs Double Humanized TargetsGraft-versus-Host / Engraftment Considerations
Graft-versus-Host / Engraftment ConsiderationsView All TermsHomologous Recombination